Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNBC
2326
DELISTED
First NBC Bank Holding Company
FNBC
| $493K | ﹤0.01% |
14,700
-16,369
| -53% | -$536K |
|
|
ATAXZ
2327
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
| $493K | ﹤0.01% |
81,895
-76,043
| -48% | -$458K |
|
2328
American Eagle Outfitters
AEO
$2.72B
| $491K | ﹤0.01% |
43,763
-187,252
| -81% | -$2.13M |
|
|
CBR
2329
DELISTED
CIBER Inc.
CBR
| $491K | ﹤0.01% |
99,480
-27,739
| -22% | -$126K |
|
|
ASXC
2330
DELISTED
Asensus Surgical, Inc.
ASXC
| $490K | ﹤0.01% |
+7,477
| New | +$432K |
|
|
TPI
2331
DELISTED
TIANYIN PHARMACEUTICAL
TPI
| $490K | ﹤0.01% |
680,100
+60,000
| +10% | +$47.4K |
|
|
TCF
2332
DELISTED
TCF Financial Corporation Common Stock
TCF
| $489K | ﹤0.01% |
17,432
+11,132
| +177% | +$326K |
|
2333
Monro
MNRO
$359M
| $488K | ﹤0.01% |
+9,179
| New | +$503K |
|
|
WSTC
2334
DELISTED
West Corporation
WSTC
| $488K | ﹤0.01% |
18,200
+7,257
| +66% | +$185K |
|
|
ALBO
2335
DELISTED
Albireo Pharma Inc
ALBO
| $487K | ﹤0.01% |
7,522
+1,359
| +22% | +$94.5K |
|
|
OCRX
2336
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $487K | ﹤0.01% |
63,749
+26,700
| +72% | +$213K |
|
|
FWDI
2337
Forward Industries Inc
FWDI
$305M
| $486K | ﹤0.01% |
39,830
+1,500
| +4% | +$22.1K |
|
2338
Kelly Services Class A
KELYA
$536M
| $484K | ﹤0.01% |
+28,207
| New | +$555K |
|
2339
Lifeway Foods
LWAY
$447M
| $484K | ﹤0.01% |
34,600
-1,600
| -4% | -$22.4K |
|
|
DTLK
2340
DELISTED
Datalink Corp
DTLK
| $483K | ﹤0.01% |
48,300
+21,833
| +82% | +$238K |
|
2341
Bank of Marin Bancorp
BMRC
$462M
| $482K | ﹤0.01% |
21,152
+11,950
| +130% | +$266K |
|
|
AXU
2342
DELISTED
Alexco Resource Corp
AXU
| $482K | ﹤0.01% |
382,700
+10,900
| +3% | +$13.9K |
|
2343
DHI Group
DHX
$166M
| $478K | ﹤0.01% |
62,750
-260,135
| -81% | -$1.85M |
|
|
PRSS
2344
DELISTED
CafePress Inc.
PRSS
| $478K | ﹤0.01% |
92,500
+11,201
| +14% | +$62.7K |
|
|
BCA
2345
DELISTED
CORPBANCA SPONSORED ADR REPSTG (1-1,500)COM STK
BCA
| $476K | ﹤0.01% |
25,554
-18,704
| -42% | -$340K |
|
|
DVCR
2346
DELISTED
Diversicare Healthcare Services Inc
DVCR
| $474K | ﹤0.01% |
62,500
+1,800
| +3% | +$12.1K |
|
|
SSNI
2347
DELISTED
Silver Spring Networks, Inc.
SSNI
| $473K | ﹤0.01% |
+35,500
| New | +$484K |
|
2348
Hurco Companies Inc
HURC
$144M
| $472K | ﹤0.01% |
16,753
-12,729
| -43% | -$349K |
|
|
TISA
2349
DELISTED
TOP Image Systems Ltd
TISA
| $470K | ﹤0.01% |
119,283
-17,317
| -13% | -$68.6K |
|
2350
Clean Harbors
CLH
$16.7B
| $469K | ﹤0.01% |
+7,302
| New | +$434K |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.